was read the article
array:22 [ "pii" => "S1665268123000108" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.100906" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "100904.2" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2023;28 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S166526812300011X" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.100907" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "100904.3" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2023;28 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Raquel Horrillo, Anna Mestre, Alba Pérez, Jordi Vidal, Estefania Alcaraz, Mireia Torres, Vicente Arroyo, Javier Fernández, Joan Clària, Montserrat Costa" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Raquel" "apellidos" => "Horrillo" ] 1 => array:2 [ "nombre" => "Anna" "apellidos" => "Mestre" ] 2 => array:2 [ "nombre" => "Alba" "apellidos" => "Pérez" ] 3 => array:2 [ "nombre" => "Jordi" "apellidos" => "Vidal" ] 4 => array:2 [ "nombre" => "Estefania" "apellidos" => "Alcaraz" ] 5 => array:2 [ "nombre" => "Mireia" "apellidos" => "Torres" ] 6 => array:2 [ "nombre" => "Vicente" "apellidos" => "Arroyo" ] 7 => array:2 [ "nombre" => "Javier" "apellidos" => "Fernández" ] 8 => array:2 [ "nombre" => "Joan" "apellidos" => "Clària" ] 9 => array:2 [ "nombre" => "Montserrat" "apellidos" => "Costa" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526812300011X?idApp=UINPBA00004N" "url" => "/16652681/00000028000000S1/v2_202308150516/S166526812300011X/v2_202308150516/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S1665268123000091" "issn" => "16652681" "doi" => "10.1016/j.aohep.2023.100905" "estado" => "S300" "fechaPublicacion" => "2023-03-01" "aid" => "100904.1" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "abs" "cita" => "Ann Hepatol. 2023;28 Supl 1:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Wai Kay Seto, Ting-Tsung Chang, Abhijit Chowdhry, Chi-Yi Chen, Mustafa Kemal Celen, Xiaoli Ma, Mang Ma, Ajay Duseja, Ki Tae Yoon, Wan Cheng Chow, Leland Yee, Gregor Weber, Ms Jin Youn, John F. Flaherty, Anuj Gaggar, Bing Gao, Gregory Camus, Eric Bassetti, Jae Seok Hwang, Tetshuro Inokuma, Young- Suk Lin, Edward J. Gane" "autores" => array:22 [ 0 => array:2 [ "nombre" => "Wai Kay" "apellidos" => "Seto" ] 1 => array:2 [ "nombre" => "Ting-Tsung" "apellidos" => "Chang" ] 2 => array:2 [ "nombre" => "Abhijit" "apellidos" => "Chowdhry" ] 3 => array:2 [ "nombre" => "Chi-Yi" "apellidos" => "Chen" ] 4 => array:2 [ "nombre" => "Mustafa Kemal" "apellidos" => "Celen" ] 5 => array:2 [ "nombre" => "Xiaoli" "apellidos" => "Ma" ] 6 => array:2 [ "nombre" => "Mang" "apellidos" => "Ma" ] 7 => array:2 [ "nombre" => "Ajay" "apellidos" => "Duseja" ] 8 => array:2 [ "nombre" => "Ki Tae" "apellidos" => "Yoon" ] 9 => array:2 [ "nombre" => "Wan Cheng" "apellidos" => "Chow" ] 10 => array:2 [ "nombre" => "Leland" "apellidos" => "Yee" ] 11 => array:2 [ "nombre" => "Gregor" "apellidos" => "Weber" ] 12 => array:2 [ "nombre" => "Ms Jin" "apellidos" => "Youn" ] 13 => array:2 [ "nombre" => "John F." "apellidos" => "Flaherty" ] 14 => array:2 [ "nombre" => "Anuj" "apellidos" => "Gaggar" ] 15 => array:2 [ "nombre" => "Bing" "apellidos" => "Gao" ] 16 => array:2 [ "nombre" => "Gregory" "apellidos" => "Camus" ] 17 => array:2 [ "nombre" => "Eric" "apellidos" => "Bassetti" ] 18 => array:2 [ "nombre" => "Jae Seok" "apellidos" => "Hwang" ] 19 => array:2 [ "nombre" => "Tetshuro" "apellidos" => "Inokuma" ] 20 => array:2 [ "nombre" => "Young- Suk" "apellidos" => "Lin" ] 21 => array:2 [ "nombre" => "Edward J." "apellidos" => "Gane" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123000091?idApp=UINPBA00004N" "url" => "/16652681/00000028000000S1/v2_202308150516/S1665268123000091/v2_202308150516/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE" "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Lucas Opazo-Rios, Manuel Soto-Catalan, Iolanda Lázaro, Aleix Sala-Vila, Cristian Pérez-Gallardo, Fabian Segovia-Miranda, Juan Antonio Moreno, Jesús Egido, Sebastián Mas-Fontao" "autores" => array:9 [ 0 => array:3 [ "nombre" => "Lucas" "apellidos" => "Opazo-Rios" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">2</span>" "identificador" => "aff0002" ] ] ] 1 => array:3 [ "nombre" => "Manuel" "apellidos" => "Soto-Catalan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 2 => array:3 [ "nombre" => "Iolanda" "apellidos" => "Lázaro" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">3</span>" "identificador" => "aff0003" ] ] ] 3 => array:3 [ "nombre" => "Aleix" "apellidos" => "Sala-Vila" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">3</span>" "identificador" => "aff0003" ] ] ] 4 => array:3 [ "nombre" => "Cristian" "apellidos" => "Pérez-Gallardo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">4</span>" "identificador" => "aff0004" ] ] ] 5 => array:3 [ "nombre" => "Fabian" "apellidos" => "Segovia-Miranda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">4</span>" "identificador" => "aff0004" ] ] ] 6 => array:3 [ "nombre" => "Juan Antonio" "apellidos" => "Moreno" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">5</span>" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "Jesús" "apellidos" => "Egido" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] 8 => array:3 [ "nombre" => "Sebastián" "apellidos" => "Mas-Fontao" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "aff0001" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28040 Madrid, Spain" "etiqueta" => "1" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "Facultad de Ciencias de la Salud, Universidad de Las Américas, 4301099, Concepción-Talcahuano, Chile" "etiqueta" => "2" "identificador" => "aff0002" ] 2 => array:3 [ "entidad" => "Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain" "etiqueta" => "3" "identificador" => "aff0003" ] 3 => array:3 [ "entidad" => "Department of Cell Biology, Faculty of Biological Sciences, Universidad de Concepción, Concepción, Chile" "etiqueta" => "4" "identificador" => "aff0004" ] 4 => array:3 [ "entidad" => "Department of Cell Biology, Physiology and Immunology, University of Cordoba; Maimonides Biomedical Research Institute of Cordoba (IMIBIC); UGC Nephrology, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain" "etiqueta" => "5" "identificador" => "aff0005" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Figure 1</span>:<elsevierMultimedia ident="fig0001"></elsevierMultimedia></p><p id="para0006" class="elsevierStylePara elsevierViewall">Created with BioRender.com</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0001">Introduction and Objectives</span><p id="spara001" class="elsevierStyleSimplePara elsevierViewall">The new recommendations suggesting changing the current nomenclature from Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic associated fatty liver disease (MAFLD) are primarily aimed at improving the understanding of the disease. MAFLD is a hepatic manifestation of metabolic syndrome and is usually associated with obesity and type 2 diabetes, excluding other causes not associated with positive energy balance. This study aimed to characterize the pathophysiological mechanism involved in MAFLD development in susceptible-strain Black Tan and brachyuric (BTBR) insulin-resistant mice in combination with leptin deficiency (ob/ob).</p></span> <span id="abss0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0002">Materials and Methods</span><p id="spara002" class="elsevierStyleSimplePara elsevierViewall">We studied liver morphology and biochemistry on our diabetic and obese mice model (BTBR ob/ob) as well as a diabetic non-obese control (BTBR + streptozotocin) and non-diabetic control mice (BTBR wild type) from 4-22 weeks. The lipid composition was assessed and lipid-related pathways were studied at transcriptional and protein levels.</p></span> <span id="abss0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Results</span><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Microvesicular steatosis was evident in BTBR ob/ob from week 6, progressing to macrovesicular in the following weeks. At the 12th week, inflammatory clusters, activation of STAT3 and Nrf2 signaling pathways, and hepatocellular ballooning. At 22 weeks, the histopathological features previously observed were maintained and no signs of fibrosis were detected. Liver gene-expression analysis demonstrated modifications in fatty acid transporters associated with uptake (Cd36, Cd204, Fatp4)/efflux (Abca1, Abcg1), <span class="elsevierStyleItalic">de novo</span> fatty acid synthesis enzymes (ACC, FASN, SCD-1) and transcription factors related to lipogenic pathways (Pparα/γ, Srebp-1, Chrebp-1). Additionally, the lipidomic analysis showed profiles associated with de novo lipogenesis (DNL), showing a significant increase in palmitic acid (C16:0), palmitoleic acid (C16:1n7) and oleic acid (C18:1n9).</p></span> <span id="abss0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Conclusions</span><p id="spara004" class="elsevierStyleSimplePara elsevierViewall">BTBR ob/ob mice develop MAFLD profiles that resemble pathological features observed in humans, with overactivation of inflammatory response, oxidative stress and DNL signaling pathways. Therefore, BTBR ob/ob mouse is an excellent model for the study of the steatosis to steatohepatitis transition.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abss0001" "titulo" => "Introduction and Objectives" ] 1 => array:2 [ "identificador" => "abss0002" "titulo" => "Materials and Methods" ] 2 => array:2 [ "identificador" => "abss0003" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abss0004" "titulo" => "Conclusions" ] ] ] ] "multimedia" => array:1 [ 0 => array:6 [ "identificador" => "fig0001" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1093 "Ancho" => 1667 "Tamanyo" => 230500 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Unlabelled imag" "rol" => "short" ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000028000000S1/v2_202308150516/S1665268123000108/v2_202308150516/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000028000000S1/v2_202308150516/S1665268123000108/v2_202308150516/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268123000108?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 1 | 0 | 1 |
2024 October | 11 | 7 | 18 |
2024 September | 16 | 3 | 19 |
2024 August | 30 | 4 | 34 |
2024 July | 16 | 5 | 21 |
2024 June | 14 | 4 | 18 |
2024 May | 21 | 1 | 22 |
2024 April | 17 | 7 | 24 |
2024 March | 13 | 3 | 16 |
2024 February | 9 | 6 | 15 |
2024 January | 18 | 4 | 22 |
2023 December | 9 | 6 | 15 |
2023 November | 7 | 4 | 11 |
2023 October | 11 | 3 | 14 |
2023 September | 6 | 6 | 12 |
2023 August | 9 | 2 | 11 |
2023 July | 4 | 5 | 9 |
2023 June | 3 | 1 | 4 |
2023 May | 7 | 1 | 8 |
2023 April | 1 | 0 | 1 |
2023 March | 1 | 0 | 1 |